Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 192

1.

Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.

Papworth K, Bergh A, Grankvist K, Ljungberg B, Sandlund J, Rasmuson T.

Acta Oncol. 2013 Jan;52(1):159-65. doi: 10.3109/0284186X.2012.693623. Epub 2012 Jun 26.

PMID:
22731830
[PubMed - indexed for MEDLINE]
2.

Higher expression of K-ras is associated with parathyroid hormone-related protein-induced hypercalcaemia in renal cell carcinoma.

Kamai T, Arai K, Koga F, Abe H, Nakanishi K, Kambara T, Furuya N, Tsujii T, Yoshida KI.

BJU Int. 2001 Dec;88(9):960-6.

PMID:
11851621
[PubMed - indexed for MEDLINE]
3.

Prognostic role of bone sialoprotein in clear cell renal carcinoma.

Righi L, Bollito E, Ceppi P, Mirabelli D, Tavaglione V, Chiusa L, Porpiglia F, Brunelli M, Martignoni G, Terrone C, Papotti M.

Anticancer Res. 2013 Jun;33(6):2679-87.

PMID:
23749927
[PubMed - indexed for MEDLINE]
4.

Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.

Sandlund J, Oosterwijk E, Grankvist K, Oosterwijk-Wakka J, Ljungberg B, Rasmuson T.

BJU Int. 2007 Sep;100(3):556-60. Epub 2007 Jul 3.

PMID:
17608827
[PubMed - indexed for MEDLINE]
5.

Evaluation of CD31 (PECAM-1) expression using tissue microarray in patients with renal cell carcinoma.

Sandlund J, Hedberg Y, Bergh A, Grankvist K, Ljungberg B, Rasmuson T.

Tumour Biol. 2007;28(3):158-64. Epub 2007 May 18.

PMID:
17510564
[PubMed - indexed for MEDLINE]
6.

Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.

Papworth K, Grankvist K, Ljungberg B, Rasmuson T.

Tumour Biol. 2005 Jul-Aug;26(4):201-6. Epub 2005 Jul 7.

PMID:
16006777
[PubMed - indexed for MEDLINE]
7.

Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.

Papworth K, Sandlund J, Grankvist K, Ljungberg B, Rasmuson T.

Anticancer Res. 2010 Jul;30(7):2953-7.

PMID:
20683038
[PubMed - indexed for MEDLINE]
8.

Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.

Matusan K, Dordevic G, Stipic D, Mozetic V, Lucin K.

J Surg Oncol. 2006 Sep 15;94(4):325-31.

PMID:
16917865
[PubMed - indexed for MEDLINE]
9.

Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.

Sandlund J, Ljungberg B, Wikström P, Grankvist K, Lindh G, Rasmuson T.

Acta Oncol. 2009;48(6):909-14. doi: 10.1080/02841860902824891.

PMID:
19322701
[PubMed - indexed for MEDLINE]
10.

Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.

Rogenhofer S, Kahl P, Mertens C, Hauser S, Hartmann W, Büttner R, Müller SC, von Ruecker A, Ellinger J.

BJU Int. 2012 Feb;109(3):459-65. doi: 10.1111/j.1464-410X.2011.10278.x. Epub 2011 Aug 2.

PMID:
21810159
[PubMed - indexed for MEDLINE]
11.

Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma.

Iwamura M, Wu W, Muramoto M, Ohori M, Egawa S, Uchida T, Baba S.

Cancer. 1999 Sep 15;86(6):1028-34.

PMID:
10491530
[PubMed - indexed for MEDLINE]
12.

The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.

Li JF, Chu YW, Wang GM, Zhu TY, Rong RM, Hou J, Xu M.

BJU Int. 2009 Feb;103(3):399-405. doi: 10.1111/j.1464-410X.2008.08151.x. Epub 2008 Nov 19.

PMID:
19021626
[PubMed - indexed for MEDLINE]
13.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.

PMID:
22044519
[PubMed - indexed for MEDLINE]
14.

Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.

Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP.

Tumour Biol. 2006;27(1):1-7. Epub 2005 Dec 8.

PMID:
16340244
[PubMed - indexed for MEDLINE]
15.

Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.

Cheville JC, Lohse CM, Sukov WR, Thompson RH, Leibovich BC.

Am J Surg Pathol. 2012 Jun;36(6):851-6. doi: 10.1097/PAS.0b013e3182496895.

PMID:
22367296
[PubMed - indexed for MEDLINE]
16.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472
[PubMed - indexed for MEDLINE]
17.

Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.

Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV.

Eur Urol. 2005 Oct;48(4):593-600.

PMID:
15964127
[PubMed - indexed for MEDLINE]
18.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
[PubMed - indexed for MEDLINE]
19.

Paraneoplastic hormones: parathyroid hormone-related protein (PTHrP) and erythropoietin (EPO) are related to vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma.

Feng CC, Ding GX, Song NH, Li X, Wu Z, Jiang HW, Ding Q.

Tumour Biol. 2013 Dec;34(6):3471-6. doi: 10.1007/s13277-013-0924-7. Epub 2013 Jun 19.

PMID:
23780896
[PubMed - indexed for MEDLINE]
20.

Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma.

Miyata Y, Kanda S, Sakai H, Greer PA.

Cancer Sci. 2013 Jun;104(6):681-6. doi: 10.1111/cas.12140. Epub 2013 Apr 18.

PMID:
23445469
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk